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In connection with a study to determine whether man could be
successfully immunized against bacillary dysentery it was necessary to
determine the infective dose of dysentery bacilli by feeding living
Shigella to human volunteers. The only previous information con-
cerning the susceptibility of man to experimental infection is contained
in a few published observations' 3 of accidental laboratory-infections.
These indicated that man was susceptible to rather large doses of
dysentery bacilli, but they gave no other information.
TABLE 1
SOURCE, VIRULENCE AND SULFADIAZINE SUSCEPTIBILITY
OF STRAINS OF SHIGELLA PARADYSENTERIAE (FLEXNER W)
Highestdilution
ofsulfadiazine
Source LDso givingcomplete
Ourdesignation designation formice inhibition
FWI 2-13* 10-7.5 1:500
FWII 2633## 10M. 1:400
FWIII 3050* 104.2 1:400
FWIV 43G72 104-5 1:200
FWV 2-10# 104-7 1:200
FWVI 7989*# 10J7+ 1:100
FWvaccine strain 79-118-2W*# # 10-8 1:50
*Supplied by Army Medical School.
*'Supplied by Connecticut Department of Health Laboratories.
"'#Isolated in Illinois Department of Health Laboratories.
* "' *Supplied by Dr. A. J. Weil.
* From the Division of Laboratories, Illinois Department of Public Health, and the
Samuel Deutsch Serum Center, Michael Reese Research Foundation, Chicago, Illinois.
The work described in this paper was done under a contract, recommended by the
Committee on Medical Research, between the Office of Scientific Research and Development
and the Michael Reese Research Foundation.
Grateful acknowledgement is made of the aid and encouragement given to this study
by Mr. T. P. Sullivan, Director of Public Safety, State of Illinois, and Dr. Roland R. Cross,
Director of Public Health, State of Illinois, without which the study would not have been
possible. We are especially indebted to Mr. James M. Ragen, Warden, Illinois State
Penitentiary, and his staff who provided facilities and personnel and cooperated whole-
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In the study mentioned above human volunteers were fed graded
doses of recently isolated strains of Flexner W organisms which had
been shown to be sensitive to sulfadiazine. For details of the source,
mouse virulence, and sulfadiazine susceptibility, see table 1. The
technique by which susceptibility to sulfadiazine was determined is
described in a previous paper.2
Before a volunteer was accepted for participation in the study he
was required to pass a physical examination. Two rectal swabs, collected
on different days, from each volunteer were cultured for Shigella on
S. S. agar and only those individuals with negative cultures and a
negative history of a recent diarrheal illness were accepted.
Oral temperatures were taken once daily on each volunteer for one
week prior to administration of the challenge dose. During the day of
the challenge, for at least 48 hours thereafter, and during clinical illness
temperatures were taken four times daily. Temperature readings were
then made twice a day until two weeks after the challenge.
Rectalswabsfromeachvolunteer were cultured atdaily intervals for
three days just prior to exposure to the challenge infection. Rectal swab
cultures were also made daily while the patients were under observa-
tion following their exposure to challenge infection.
The organisms used for challenge were grown on veal infusion
agar slants, the growth washed off with distilled water just prior to
challenge, and the number of organisms per cubic centimeter was ad-
justed by comparison with nephelometer standards. The results of
nephelometric standardization were checked by plate counts until it was
decided that nephelometer measurements were accurate enough for
the purpose. The subjects were first prepared for the challenge by
giving each one dram of paregoric 3½V2 hours after a meal, followed
30 minutes later by two gm. of powdered sodium bicarbonate in one
ounce of water. Five minutes later, the dysentery bacilli were given,
suspended in one-half pint of milk. The administration of paregoric
was repeated at the end of 3 and 6 hours.
It was later thought that the use of milk might be interfering
with the effects of thechallenge material. Itwas, therefore, discontinued
and the later challenge doses were administered in a glass of water,
followed immediately by another glass of water, in order to dilute the
gastric secretions and to wash the material through the stomach quickly.
The subjects used in determining the infective dose were challenged
in groups of four. It was planned that each of those of the first group be
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fed 100 million living Shigella organisms. Failing to infect two of the
four, the next group were to receive one billion living organisms, and
subsequent groups larger numbers in an attempt to find the dosage
that produced a fifty per cent, or more, attack rate in unvaccinated
controls.
Since we were interested only in whether or not dysentery could
be produced in a given individual, sulfadiazine was administered as
soon as a definite diagnosis of dysentery could be made. In later experi-
ments, after the infective dose had been established, those who did not
show signs or symptoms of dysentery within four days after challenge
were given a course of sulfadiazine therapy in order to prevent them
from becoming dysentery carriers. The dosage of sulfadiazine was
approximately one grain per pound of body weight per day in four
divided doses for five to seven days.
All organisms isolated from any of the daily rectal swabs were
identified by cultural, biochemical, tinctorial, and immunologic tests.
Daily swabs for culture were taken until at least five consecutive
negative cultures were obtained. After cessation of sulfadiazine therapy
usually at least two negatives were obtained and in no case was any
subject released from isolation until at least three successive negative
cultures were obtained on specimens taken 24 hours apart.
In the first groups of experiments strain FW I was used and, as
shown in table 2, the volunteers given 100 million, 1 billion, and 10
billion organisms, respectively, in milk failed to develop definite clinical
dysentery. Two men given 10 billion organisms in water developed
mild dysentery. There was no temperature elevation, but these two
patients had cramps, headache, chills, and passed frequent, watery
stools, one having six bowel movements and the other nine in one day.
On the basis of these findings it was believed the end-point was
being reached and accordingly the four volunteers in the next group
were fed only 15 billion organisms, strain FW I, in water. Since none
of these showed any signs or symptoms during the subsequent 48 hours,
they were given 15 billion more organisms on each of the next two
days. Since there was virtually no result from this, 50 billion dysentery
bacilli were administered on the fourth day. The only reactions to these
massive doses of organisms were mild headache, anorexia, slight ab-
dominal cramps, and an occasional soft stool.
It was obvious that strain FW I, although the most virulent for
mice, was not virulent enough to produce clean-cut clinical infection in
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TABLE 2
RESULTS IN MEN GIVEN SHIGELLA
No. Org. Rectal swab cultures Dysentery
100 million P P O OO o No
OO P O O (O No
FW I 0 P 0 0 0 0 0 Questionable
O P P P P P O No
I billion O PP P OO PO No
O PPPP PO O- Questionable
FW I o p p O p 0 0 0 Questionable
O p p p O0 0 0 Questionable
10 billion 0 0p0 0 0 0 Questionable
FW I O PPPP POO P O Questionable
in milk 0 p p o)0 00 Questionable
OPOPPPPO No
IO billion 00 P Pp o -O No
FW I 0 P0 0- P Mild
in water O p p pP p pp O Questionable
OP PP POOO Mild
95 billion OO P PP P P PP O No
FW I, OO PPPP PO OO No
divided OO PPPP PO CO No
doses OO OOP PPPO O No
10 billion; 0 -~Neg. 20 Days --b. 0 0 Severe
mixed strains O P O O O Questionable
plus infected. 0 P 0 0 0 Moderate
feces O PO P O Severe
Infected 0 000000 No
feces 0 0000 00 No
alone 0 00 0000 No
0 0 000 00 No
10 billion; O P O OO OOO Severe
mixed O P 0 000 Moderate
strains O PPPP OOO Moderate
O PPOQO OO Moderate
t_
10 billion; 0 p p0 0 00 Questionable
mixed strains 0 P pp0 0P 0 - Mild
plus normal O p pp0 0P No
feces O p p 00 0 0 Moderate
It
I billion; P p 0 00 0 0 - Mild
mixed P p O00 0 0 ° Questionable
strains P PPPO OO Moderate
+ Indicates beginning of chemotherapy
_ Indicates all subsequent specimens were negativeDYSENTERY IN HUMAN VOLUNTEERS
man, even in overwhelming doses. It was thought that some adjuvant
might be needed, perhaps some factor present in infected feces. For
these reasons the next group of eight subjects was divided into two
groups of four each. Four subjects were fed a mixture containing 2.5
billion each of the four strains FW II, FW III, FW IV, and FW V in
water. At the same time they were given a gelatin capsule containing
about 1 gm. of feces collected on the day of the challenge from case
A. C. This patient's feces were known to contain Flexner W organisms
in large number. The other four subjects were each given capsules con-
taining 1 gm. ofinfected feces alone. Thiswas immediately washeddown
with copious amounts of water. Paregoric was omitted in these tests.
One of the subjects given feces alone had several watery stools on each
of three days, mild headache and cramps, but no elevation of tempera-
ture. The others had only minor complaints of anorexia, cramps, or
headache. It is of interest that none of these four volunteers excreted
FlexnerW organisms atany time. Oneofthem began to excreteShigella
alkalescens on the same day that the feces were fed, although his
previous cultures and those of the "donor" of the feces had not shown
the presence of this organism.
In contrast to the essentially negative findings with the infected
feces alone, three of the four subjects fed feces plus the mixture of four
strains of dysentery bacilli developed definite signs and symptoms of
clinical dysentery. Moderately severe cramps, headache, and vomiting
appeared about 12 hours after the test dose was given. On the following
day the temperature rose to 103.4, 104.4, and 1050, respectively, and
the patients were toxic and prostrated. The maximum number of stools
per day were six, eight, and nine, respectively. Mucus was present in the
feces of all three and one patient's feces showed streaks of blood. Sul-
fadiazine therapy was begun on the day following the challenge so that
the cultures became negative almost immediately. In one instance a
single positive finding was obtained on a culture made three weeks after
the challenge, but sulfadiazine therapy was reinstituted and subsequent
cultures taken over an 18-day period were negative.
These results seemed to indicate that the infected feces might have
acted as an adjuvant. However, as we had used a mixture of four new
strains in the last attempt, it was necessary to establish whether the new
strains or the addition of feces was responsible for the production of
clear-cutclinicaldysentery. Thenextgroupconsistedofeightindividuals,
four of whom received a total of 10 billion Flexner W, strains F II,
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III, IV, and V, in water, while the other four received the same number
of organisms of the same strains and, in addition, each swallowed a
capsule containing about 1 gm. of feces from a normal individual.
All of the subjects who received organisms alone had severe clinical
dysentery with maximum temperatures of 103 to 1040, four to ten
watery stools containing blood and mucus, and moderately severe to
severe cramps, vomiting, and chills. On the other hand, only one of
the four who receivedthe same dose of organisms plus normal feces had
definite dysentery and his infection was milder than those experienced
by the other group. Organisms appeared in the feces of the subjects
receiving feces plus organisms just as early and persisted for as long
as, or longer than, in those who were given organisms alone.
From these results it appeared that fecal material was not necessary
and subsequent tests were performed with bacteria in water alone.
Since we wished to obtain an infectivity rate of about 50 per cent, the
three individuals in the next group were given a mixture of 625 million
of each of the four strains, FW II, FW III, FW IV, and FW V in water.
The usual 2 gm. of sodium bicarbonate were administered five minutes
previously. Two of these subjects had a moderate form of clinical
dysentery with temperatures of 101.4 and 1020, three or four watery or
semi-solid stools, cramps, and vomiting. Cultures became positive the
day after the ingestion of the challenge culture and remained positive
for from one to three days after sulfadiazine therapy was begun.
It would have been desirable if we could have determined, prior to
further studies, whether any of the four strains used to infect the
subjects in the last four groups of volunteers could produce infection
when ingested alone or whether a combination of the strains was
necessary. An insufficient number of volunteers remained, however, to
make the extensive tests necessary to settle this point. It was, therefore,
decided to challenge the vaccinated groups and their controls with
mixtures of the four strains of Flexner W used in the experiments
described above. The LDso for mice of this four-strain mixture was
found to be 10-5.8. Subsequent tests with the single strains indicated that
each one could produce clinical dysentery.
Thevaccinated men and theirunvaccinatedcontrols were challenged
with mixtures of the four strains used above in dosages of from one to
four billion organisms. The results of these tests, which were negative,
have been reported elsewhere.2 The incubation period, symptomatology,
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and duration of illness of the men included in these experiments have
been tabulated and will be discussed here.
In analyzing the results it was necessary to define the clinical entity,
dysentery. This was not easy, but it was finally decided that to be
considered as a case of dysentery, the subject must have had a tempera-
ture of at least 100° F. by mouth during at least one of the four days
followingthe feedingofShigellaorganisms orhe musthavepassed three
or more stools, at least one of which was watery, during any one day
of the week following the challenge. To be considered as a moderate or
severe case of dysentery, the subject must have had a temperature of
more than 1010 F. by mouth during at least one of the four days
following the challenge and, in addition, at least three stools in one day
or, alternatively, five or more stools during any one day, at least two of
which were watery, and he must have experienced chills, severe cramps,
or vomiting.
Based on these criteria 32 volunteers contracted mild dysentery and
51 moderate or severe dysentery, while 56 escaped infection entirely.
Most of those who did not contract the disease received ineffective
material during the course of the earlier experiments mentioned above.
However, even in the later experiments, 23 of the 83 subjects escaped
infection, regardless of their previous status in regard to vaccination.
In those subjects who developed the disease the incubation periods
were remarkably short. All of those developing moderate or severe
dysentery showed definite signs and symptoms within 24 hours after
receiving the challenge dose. About one-fourth of these cases had in-
cubationperiodsunder 12 hours. In those whodeveloped mild dysentery
the incubation periods were somewhat lengthened. Twenty of the 32
cases developed definite signs of infection, such as diarrhea or tempera-
ture elevation over 1000 F., within 24 hours after challenge, nine in
24 to 36 hours, two in 36 to 48 hours and only one delveloped his first
symptoms three days after the challenge. The incubation periods were
short, initial symptoms usually appearing within 48 hours, even in those
individuals who showed only mild abdominal cramps, headache, bloat-
ing, etc., such slight symptoms that a diagnosis of dysentery was
questionable.
The signs and symptoms exhibited by the infected individuals are
shown in Figs. 1 and 2. As might be expected, the principal sign shown
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DIARRHEA 84$
I4YPERPYREXIA 82%
ABDOMINAL CRAMPS 78%
MUCUS IN FECES 57%
CHILLS 55%
ANOREXIA 53%
NAUSEA 51%
VOMITING 49%
ABDOMINAL TENDERHESS 47%
41%
20 40 SO
PERCENT
FIG. 1. Signs and symptoms in 51 cases of
moderate or severe dysentery.
HYPERPYREXIA 75%
ABDOMINAL CRAMPS 69%
HEADACHE 59%
ANOREXIA 47%
DIARRHEA 34%
CHILLS 34%
NAUSEA 19%
ABDOMINAL TENDERNESS 16%
9%
20 40 60 so
PERCENT
ymptoms in 32 cases of
dysentery.
by those with moderate or
severe dysentery was diar-
rhea, but only 84 per cent
of this group were recorded
as having diarrhea. This is
accounted for by the fact
that there were a few cases
in this series in which the
patients hadahightempera-
ture, severe abdominal
cramps, and several bowel
movements in one day all
of which, however, were
solid or semi-solid. The
prominent position of
nausea and vomiting in the
list of signs and symptoms
shown by those having
moderate or severe dysen-
tery is noteworthy. The his-
tories often indicated that
the patient began to exhibit
nausea and vomiting, to-
gether with abdominal
cramps, before any other
signs or symptoms were
manifest.
In the group which ex-
perienced only mild dysen-
tery, the most prominent
sign was temperature eleva-
tion, while diarrhea was ex-
hibited by only one-third of
these cases. The importance
of anorexia and headache
and the insignificant per-
centage of cases showing
vomiting are worthy of
record.
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HEADACHE
BLOOD IN FECES 23%
VOMITING
MUCUS IN FECES 6%
BLOOD IN FECES 0%
FIG. 2. Signs and s
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One of the puzzling differences in the two series is the difference in
the percentage of individuals who had headache. The latter symptom
was found in 59 per cent of the mild cases but in only 41 per cent of
the moderate or severe cases. Furthermore, headache was complained
of for a longer period of time by the mild cases than by the more
severe ones. This difference may have been due to chance. It is
also possible that it was due to the more rapid removal of toxic sub-
stances by the greater degree of purging experienced by the more severe
cases. The more severe purging may also have removed gas from the
bowel and hence removed a source of headache caused by distention
of the rectum by gas. Finally, of course, it must be admitted that the
sicker individuals may have had their attention riveted to more serious
symptoms so that they neglected to complain of headache.
As would be expected, the duration of illness was longer in the
group with moderate or severe dysentery than in those with mild in-
fection. In the former, the mean duration of illness was about 3.5 days
with a range from one to seven days. The curve of duration was quite
symmetrical with 11 cases ill for three days and 11 cases for four days.
In those showing mild dysentery the duration of the illness averaged
about two days, the range being from one to six days, most of the
cases being centered at one and two days' duration.
The relatively brief periods of illness shown by these cases can, we
believe, be accounted for to a large extent by the prompt application of
sulfadiazine and other types of symptomatic therapy. The fact that
there were no carriers following sulfadiazine therapy is also worthy of
mention. As indicated above, the infecting strain was known to be
highly susceptible to the action of sulfadiazine and this undoubtedly
accounts to a considerable extent for the rapid and effective results
obtained by using this drug.
Summary and conclusions
Experimental bacillary dysentery can be successfully produced in
man by ingestion of approximately one billion Shigella organisms in
water.
A strain of Shigella which was most virulent for mice failed to
produce clinical infection in man, while other strains of much lower
virulence for mice produced moderate or severe dysentery in man.
The incubation period in the experimental disease was usually very
short, rarely over 24 hours and never longer than 72 hours.
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Because of the prominence of nausea and vomiting, moderate or
severe bacillary dysentery might easily be confused on clinical grounds
with food infections or intoxications due to Salmonella or staphylococci
unless bacteriological tests are employed to determine the etiology.
Excretion of Shigella by asymptomatic individuals may begin within
a few hours after ingestion and continue for some time.
Sulfadiazine effectively controlled bacillary dysentery produced by
feeding sulfadiazine-susceptible strains of Shigella organisms and it
rapidly suppressed the carrier state.
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